✦ LIBER ✦

PHP32 Market Access Variation for Lifestyle Disease Drugs in Europe

✍ Scribed by A.W. Bastian; S. Gea-Sanchez; M. Tangari

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

DU3 Market Access Delays for CNS Drugs i

✍ S.J.A. Flostrand; L. Anderson; G. Esposito 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

PHP132 Time to Market Access for Innovat

✍ J. Maervoet; M. Toumi 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PHP32 Understanding Accessibility for Ne

✍ M.J. Silva; S. Rabiais; B. Vandewalle; J. Almeida; J. Félix 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PHP38 Market Access for Pharmaceuticals

✍ M.A. Izmirlieva; G. Ando; A. Bharath 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB